Net Loss per Share

6 Months Ended

Jun. 30, 2026

Earnings Per Share [Abstract]

Net Loss per Share

Net Loss per Share

The following table shows total outstanding potentially dilutive shares excluded from the computation of diluted loss per share as their effect would be anti-dilutive, as of June 30, 2026 and 2025:

	June 30,
	2026	2025
	(in thousands)
Options to purchase common stock	3,132	3,804
Performance-based awards and restricted stock units	7,321	9,498
Employee stock purchase plan	29	39
Contingent consideration	444	—
Total	10,926	13,341

As of June 30, 2026, the Company finalized a post-closing working capital adjustment related to the acquisition of Foresight Diagnostics. Certain escrowed shares that were returned to the Company in the second quarter of 2026 have been excluded from the calculation of basic and diluted earnings per share.